Get ready to experience the wonder and joy of the holiday season at La Dolce Casa’s Third Annual “Lighting of the Lights” ...

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

The annual Parkinson's fundraiser has grown from a tiny show in Asbury Park to a global concert series, thanks in part to Bruce Springsteen.

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

Funds raised aid in the battle against Parkinson's Disease and the related ALS (Amyotrophic Lateral Sclerosis) and PSP ...

ALS Awareness was a big part of this weekend’s Hickory Pick’n Day.Nikki Way was at this event as a spokesperson for her mom, ...

Aaron Lazar received his first-ever Grammy nomination on Friday, Nov. 8 for his debut album, 'Impossible Dream.' It was an ...

In September 2024, Athira announced topline results from the LIFT-AD Phase 2/3 clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease. The study did not meet its primary or key ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative neurological disorder that leads to muscle ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...